DISPOSITION OF ORAL METHOTREXATE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA AND ITS RELATION TO 6-MERCAPTOPURINE PHARMACOKINETICS

被引:0
|
作者
KOREN, G
SOLH, H
KLEIN, J
SOLDIN, SJ
GREENBERG, M
机构
[1] UNIV TORONTO,HOSP SICK CHILDREN,DIV HEMATOL ONCOL,TORONTO M5G 1X8,ONTARIO,CANADA
[2] UNIV TORONTO,HOSP SICK CHILDREN,DEPT PEDIAT,TORONTO M5G 1X8,ONTARIO,CANADA
[3] UNIV TORONTO,HOSP SICK CHILDREN,DEPT BIOCHEM,TORONTO M5G 1X8,ONTARIO,CANADA
[4] UNIV TORONTO,HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA
[5] UNIV TORONTO,HOSP SICK CHILDREN,DEPT PHARMACOL,TORONTO M5G 1X8,ONTARIO,CANADA
来源
MEDICAL AND PEDIATRIC ONCOLOGY | 1989年 / 17卷 / 06期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:450 / 454
页数:5
相关论文
共 50 条
  • [1] PHARMACOKINETICS OF ELIMINATION OF 6-MERCAPTOPURINE IN THE URINE OF CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    HERMANN, T
    CHRZANOWSKA, M
    MICHALEWSKA, D
    SKIBINSKA, L
    POLISH JOURNAL OF PHARMACOLOGY AND PHARMACY, 1985, 37 (02): : 209 - 216
  • [2] FAT-BODY MASS AND PHARMACOKINETICS OF ORAL 6-MERCAPTOPURINE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    ZUCCARO, P
    GUANDALINI, S
    PACIFICI, R
    PICHINI, S
    DIMARTINO, L
    GUIDUCCI, M
    GIULIANO, M
    DITULLIO, MT
    MANTOVANI, MP
    THERAPEUTIC DRUG MONITORING, 1991, 13 (01) : 37 - 41
  • [3] INTRAINDIVIDUAL VARIATION IN 6-MERCAPTOPURINE PHARMACOKINETICS DURING ORAL-MAINTENANCE THERAPY OF CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    LAFOLIE, P
    HAYDER, S
    BJORK, O
    PETERSON, C
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 40 (06) : 599 - 601
  • [4] Pharmacokinetics of tablet and liquid formulations of oral 6-mercaptopurine in children with acute lymphoblastic leukemia
    Rikke Hebo Larsen
    Lisa Lyngsie Hjalgrim
    Kathrine Grell
    Kim Kristensen
    Line Gerner Pedersen
    Emilie Damgaard Brünner
    Bodil Als-Nielsen
    Kjeld Schmiegelow
    Jacob Nersting
    Cancer Chemotherapy and Pharmacology, 2020, 86 : 25 - 32
  • [5] Pharmacokinetics of tablet and liquid formulations of oral 6-mercaptopurine in children with acute lymphoblastic leukemia
    Larsen, Rikke Hebo
    Hjalgrim, Lisa Lyngsie
    Grell, Kathrine
    Kristensen, Kim
    Pedersen, Line Gerner
    Brunner, Emilie Damgaard
    Als-Nielsen, Bodil
    Schmiegelow, Kjeld
    Nersting, Jacob
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 86 (01) : 25 - 32
  • [6] PHARMACOKINETICS OF ORAL AND INTRAMUSCULAR METHOTREXATE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    PEARSON, ADJ
    MILLS, S
    AMINEDDINE, HA
    LONG, DR
    CRAFT, AW
    CHESSELLS, JM
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1987, 20 (03) : 243 - 247
  • [7] ARE CHILDREN WITH LYMPHOBLASTIC-LEUKEMIA GIVEN ENOUGH 6-MERCAPTOPURINE
    LENNARD, L
    LILLEYMAN, JS
    LANCET, 1987, 2 (8562): : 785 - 787
  • [8] CELLULAR PHARMACOLOGY OF 6-MERCAPTOPURINE IN ACUTE LYMPHOBLASTIC-LEUKEMIA
    BOSTROM, B
    ERDMANN, G
    AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1993, 15 (01): : 80 - 86
  • [9] INFLUENCE OF FOOD-INTAKE ON BIOAVAILABILITY OF ORAL 6-MERCAPTOPURINE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    RICCARDI, R
    BALIS, FM
    FERRARA, P
    LASORELLA, A
    POPLACK, DG
    MASTRANGELO, R
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1986, 3 (04) : 319 - 324
  • [10] THE COURSE OF BIOLOGICAL PARAMETERS AND 6-MERCAPTOPURINE PHARMACOKINETICS DURING MAINTENANCE TREATMENT OF CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    HAYDER, S
    BJORK, O
    LAFOLIE, P
    ACTA PAEDIATRICA SCANDINAVICA, 1990, 79 (8-9): : 832 - 837